Naturally inspired. Engineered to deliver.
Transformative exosome therapeutics
Evox’s mission is to build a platform-driven technology company to spearhead the development of exosome therapeutics for the treatment of serious, life-threatening rare diseases where there are currently limited treatment options for patients and their families.
Pipeline Evox is developing an internal and partnered pipeline of exosome-based therapeutics for treating life-threatening rare diseases.
Partners Evox seeks partners that can leverage the power of our DeliverEX™ platform, as well as those who can help advance our rare disease programs.
Evox combines the highly versatile delivery capabilities of exosomes with targeting technology and sophisticated biomolecular engineering approaches.
Utilizing the DeliverEX® platform, Evox is developing an internal and partnered pipeline of exosome-based therapeutics for treating life-threatening rare diseases.
September 7, 2022
Evox announced that the Company has been granted four newly issued patents covering key purification processes and methods of exogenous loading